{{Rsnum
|rsid=4979462
|Gene=TNFSF15
|Chromosome=9
|position=114804733
|Orientation=plus
|GMAF=0.197
|Gene_s=TNFSF15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 98.5 | 1.5 | 0.0
| HCB | 51.8 | 38.0 | 10.2
| JPT | 31.0 | 44.2 | 24.8
| YRI | 36.7 | 48.3 | 15.0
| ASW | 54.4 | 38.6 | 7.0
| CHB | 51.8 | 38.0 | 10.2
| CHD | 61.5 | 33.9 | 4.6
| GIH | 95.0 | 5.0 | 0.0
| LWK | 32.7 | 51.8 | 15.5
| MEX | 65.5 | 32.8 | 1.7
| MKK | 44.2 | 44.2 | 11.5
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23000144
  |Trait=Primary biliary cirrhosis
  |Title=Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
  |RiskAllele=T
  |Pval=3E-14
  |OR=1.56
  |ORtxt=[1.39-1.76]
  |OA=1
}}

{{PMID Auto
|PMID=25028192
|Title=Associations between TNFSF15 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: A meta-analysis
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}